Brief: Cara Therapeutics Received Notice From Nasdaq That Co Is Not In Compliance With Nasdaq's Listing Rule 5450(A)(1)
Feb 2 (Reuters) - Cara Therapeutics Inc CARA.O :
* CARA THERAPEUTICS INC- ON FEB 1 RECEIVED NOTICE FROM
NASDAQ
THAT CO IS NOT IN COMPLIANCE WITH NASDAQ'S LISTING RULE
5450(A)(1)
Source text for Eikon: ID:n0001104659-24-010123
Further company coverage: CARA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM